Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

91 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

NCT00030186

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations: Not specified

View Trial Details

Completed

Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes

NCT00451997

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

NCT00144703

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

NCT00422890

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: University hospital Dresden, department of medicine Dresden, Saxony, Germany

View Trial Details

Completed

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

NCT00521664

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Klinikum Nürnberg Nord; Einheit für Knochenmarktransplantation; 5. Med. Klinik Nuremberg, Germany

View Trial Details

Completed

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

NCT00497991

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Research Site New York, United States

Research Site Houston, Texas, United States

Research Site Angers, France

Research Site Grenoble, France

View Trial Details

Completed

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

NCT00512083

Conditions: Acute Disease, Disease Attributes, Hematologic Diseases, +7 more
Locations: UCLA Medical Center Los Angeles, California, United States

Univeristy of Colorado Health Cancer Center Aurora, Colorado, United States

St. Francis Hospital and Health Center Beech Grove, Indiana, United States

University of Louisville, James Graham Brown Cancer Center Louisville, Kentucky, United States

View Trial Details

Completed

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

NCT00114764

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia

NCT00233909

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT00129168

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Not specified

View Trial Details